| |
Pharmacokinetic and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir in the ODIN trial
|
| |
| |
Reported by Jules Levin
Presented at the 10th Intl Conference on Drug Therapy in HIV in Glasgow, UK, Nov 7-11, 2010
Vanitha Sekar,1 Guy De La Rosa,2 Tom Van de Casteele,3 Sabrina Spinosa-Guzman,3 Peter Vis,3 Richard MW Hoetelmans3
1Tibotec Inc., Titusville, NJ, USA; 2Tibotec Therapeutics, Titusville, NJ, USA; 3Tibotec BVBA, Beerse, Belgium
-------------------------------
The pharmacokinetic (PK) profile of darunavir with low-dose ritonavir (DRV/r) in various multiple-dose regimens over 120 hours
Reported by Jules Levin
9th International Workshop on Clinical Pharmacology of HIV Therapy
Marta Boffito,1 Graeme Moyle,1 Andrew Hill,2,3 Vanitha Sekar,4 Eric Lefebvre,5 Martine De Pauw,3 Ralph DeMasi,4 Richard Hoetelmans3
http://www.natap.org/2008/Pharm/Pharm_13.htm
------------------------------
| |
| |
| |
|
|
|
